Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNF¿ treatment?
Tumay Ak; Leyla Mustafayeva; Yeliz Celik; Ali Yagiz Ayla; Serdal Ugurlu;
Reumatol Clin. 2023;19:175-9
2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology
Lina M. Saldarriaga-Rivera; Wilson Bautista-Molano; Alejandro Junca-Ramírez; Andrés R. Fernández-Aldana; Daniel G. Fernández-Ávila; Diego A. Jaimes; Edwin A. Jáuregui; Juan S. Segura-Charry; Consuelo Romero-Sánchez; Oscar J. Felipe-Diaz;
Reumatol Clin. 2022;18:5-14
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry
Clementina López-Medina; Lucía Otero-Varela; Fernando Sánchez-Alonso; Vega Jovaní; Lorena Expósito-Pérez; Sheila Melchor-Díaz; Yanira Pérez-Vera; Paula Pretel-Ruiz; Javier Manero; Antonio Mera-Varela; Lourdes Mateo; Dolores Ruiz-Montesino; José Andrés Lorenzo-Martín; Teresa Pedraz-Penalva; Isabel Castrejón;
Reumatol Clin. 2025;21: